Concepedia

Mark J. Morris

MJ

9

Publications

879

Citations

9

H-Index

2007

Active since

Affiliations

Pfizer (United States)(Current)

Kent State University

Torrey Pines Institute For Molecular Studies

Scripps Research Institute

Mark J. Morris is an author at Pfizer (United States) specializing in medicine, drug discovery, and natural sciences.

Top concepts

Publications per year

2007–2014

9

Publications

9

An RNA G-Quadruplex Is Essential for Cap-Independent Translation Initiation in Human VEGF IRES

Mark J. Morris, Yoichi Negishi, Cathy Pazsint et al. · Journal of the American Chemical Society · 2010 · 203 citations

Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor

Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith et al. · ACS Medicinal Chemistry Letters · 2010 · 196 citations · Full text

, , +19

An Unusually Stable G-Quadruplex within the 5′-UTR of the MT3 Matrix Metalloproteinase mRNA Represses Translation in Eukaryotic Cells

Mark J. Morris, Soumitra Basu · Biochemistry · 2009 · 152 citations

, , +15

The porphyrin TmPyP4 unfolds the extremely stable G-quadruplex in MT3-MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells

Mark J. Morris, Katherine L. Wingate, Jagannath Silwal et al. · Nucleic Acids Research · 2012 · 143 citations · Full text

Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH)

Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 63 citations

, , +8

Rows per page

1–5 of 9